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Abstract: Combining diffuse optical tomography methods with Raman 
spectroscopy of tissue provides the ability for in vivo measurements of 
chemical and molecular characteristics, which have the potential for being 
useful in diagnostic imaging. In this study a system for Raman tomography 
was developed and tested. A third generation microCT coupled system was 
developed to combine 10 detection fibers and 5 excitation fibers with laser 
line filtering and a Cytop reference signal. Phantom measurements of 
hydroxyapatite concentrations from 50 to 300 mg/ml had a linear response. 
Fiber placement and experiment design was optimized using cadaver 
animals with live animal measurements acquired to validate the systems 
capabilities. Promising results from the initial animal experiments presented 
here, pave the way for a study of longitudinal measurements during fracture 
healing and the scaling of the Raman tomography system towards human 
measurements. 
©2015 Optical Society of America 
OCIS codes: (110.6955) Tomographic imaging; (170.0110) Imaging systems; (170.5660) 
Raman spectroscopy. 
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1. Introduction 
Raman spectroscopy provides highly specific chemical composition and molecular structure 
information on a sample. Raman spectroscopy of biological tissues is widely studied because 
the Raman spectrum of tissue is sensitive to compositional alterations caused by aging and 
disease. Early uses of Raman spectroscopy and imaging have been conducted on excised 
tissue samples in order to obtain high-quality spectra [1]. As an optical spectroscopy method, 
Raman spectroscopy is amenable to fiber optic instrumentation, which enables non-invasive 
in vivo Raman measurements. Spatially-offset Raman spectroscopy (SORS), involving 
collection of back-scattered Raman photons laterally offset from the excitation source, was 
first demonstrated in 2005 as a technique for probing subsurfaces [2]. Transmission Raman, 
involving collection of Raman photons through a sample, was later developed for non-
invasive forensic and pharmaceutical analyses [3, 4]. Since those first reports in SORS and 
transmission Raman, we have seen advances in fiber optic probe design, Raman-scattered 
photon transport theory, data preprocessing and tissue phantom models [5–10]. There is 
potential of transcutaneous Raman spectroscopy, either in a SORS or transmission approach, 
for clinical applications in bone disease and breast cancer [11–15]. 
Our research in animal models and human patients has shown potential of non-invasive 
Raman spectroscopy to monitor alterations in bone composition associated with disease or 
fracture healing [13, 16]. There are two embodiments in our translational research. The first 
embodiment is using SORS to obtain Raman spectra in a defined anatomic location such as 
the proximal tibia, wound bed or articular surface [6, 13, 17]. Another approach is detection 
of diffusely propagated photons in a 360◦ plane around the excitation source, otherwise 
known as Raman tomography. Since our first reports in 2008 [18, 19], a research focus in our 
laboratories has been development of Raman tomography for in vivo Raman imaging of bone 
in humans or animal models. Since 2010, both in a rat model and human cadaveric 
specimens, we have reported measurement of diffusely propagated photons collected from 
multiple collection angles [16, 20, 21]. Extension of these principles toward subsurface 
measurements in polymers was later reported in 2014 [22]. 
We adapted principles and analysis tools from diffuse optical tomography for Raman 
tomography. A robust method for diffuse optical tomography, including Raman, is to utilize 
multiple combined source-detector measurements through tissue with model based 
reconstruction of the parameter distribution. Optical tomography methods use transmission 
measurements of emitted signals to determine a map of the interior optical properties of the 
imaged object, and this approach can be utilized in combination with co-localized images of 
the structures from x-ray or microCT imaging. Image-guided optical tomography requires 
modeling of scattering, absorption and transmission interactions and how they affect the 
measured signal [23], using photon pathways modeled with the diffusion approximation to 
the radiation transport equation. The combination of image-defined structures with Raman 
tomography can be integrated using open access software NIRFAST (www.nirfast.org). 
NIRFAST is an open-source and publically available software tool for modeling near-infrared 
light transport in tissue [23, 24]. The combined data set requires a truly optimized hardware 
interface in order to provide a stable and reliable Raman signal estimate. 
Previous experiments acquiring transcutaneous Raman spectroscopy of bone consisted of 
illumination and detection patterns over large areas and measured predominately back-
scattered photons [25, 26]. The first Raman tomography measurements were reported in 
2008, where Raman measurements were acquired in a rectangular array 180 degrees 
separated from the illumination location, showed potential for in vivo tomographic studies 
[18, 19]. Two interfaces were designed for Raman tomography in rats, where the Raman 
signal was collected from multiple angles around an illumination source. However, these 
previous interfaces did not address a major concern in Raman spectroscopic tomography 
coupled to microCT (or x-ray), which was to ensure accurate measurement of the source and 
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detector fiber placement in a way that does not interfere with the microCT image. Multiple 
optical fibers are required to interface with the tissue to allow the acquisition of multiple 
illumination and collection patterns. Multiple illumination and collection patterns are needed 
to collect high signal to noise data in the plane of collection to enable 3D reconstruction with 
high repeatability. These requirements need to be balanced with constraints on length of 
acquisition the overall size and cost of the system. The focus in this work is around the 
development of instrumentation which would yield reliable and repeatable localized Raman 
signals from microCT-imaged bones in vivo. 
The iterative process of instrument design and building relies upon the feedback obtained 
during experimentation. In the duration of previous in vivo rat measurements, we found 
design and ergonomic factors which affected instrument performance. Thus, we completely 
redesigned and built the specimen illumination apparatus, patient interface and collection 
fibers. In this manuscript, we describe the design, build and performance of a third-generation 
Raman tomography instrument for in vivo bone measurements. 
2. Materials and methods 
2.1 Raman spectrograph 
The Raman instrument used in these experiments was a commercially-available component 
consisting of a Raman spectrograph operating at λ = 785 nm (RNX1, Kaiser Optical Systems 
Inc., Ann Arbor, MI, USA). Raman scattered photons were collected using a spectrograph 
equipped with a 100μm slit. A low frequency holographic grating produced dispersed light 
over the wavenumber region between 100cm−1 and 1800cm−1. The detector was a 1024 x 256 
pixel back-illuminated deep-depletion charge coupled device (Andor Classic, Andor 
Technologies, Belfast, United Kingdom) cooled to −75°C. Custom-designed and built optical 
fiber probes, described below, were coupled to the spectrograph using standard connectors. 
2.2 Specimen illumination design 
A custom-designed system was built to incorporate an internal Raman intensity standard and 
automated laser switching between illumination fibers. The illumination component, shown in 
Fig. 1(a), consists of a polymer fiber coupled, through telescoping optics, to a fiber switch 
unit. Laser light from the RXN1 instrument was directly coupled, by FC connector, into a 2 
meter polyperfluoro-butenylvinylether (Cytop) optical fiber. (Chromis Fiberoptics, Warren, 
NJ, USA) Fig. 1(b) shows a Raman spectrum of the Cytop polymer with filtering and without 
filtering. Laser light from the polymer cable was collimated, filtered with an 842 nm short 
pass filter (Semrock Inc., Rochester, NY, USA) and injected into the input channel on a 1x6 
optical fiber switch (Leoni, Nuremburg, Germany) using telescoping optics. Leoni 
manufactured the optical fiber switch, with crosstalk characteristics near the noise floor of 
detection and channel-to-channel intensity variation was below 6%. Illumination fibers were 
coupled into the switch system with a converging lens. Illumination fibers consisted of a 
100µm core, 125μm fiber diameter after cladding, and a total diameter of 1.23mm with the 
inclusion of the stainless steel ferrule. In-house software was written in Matlab (2013b, The 
MathWorks, Natick, MA, USA) to control the switch. The laser intensity varied between 35 
and 75mW at the tip of the illumination fiber, depending on alignment. 
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Fig. 1. Panel a shows a diagram of the optical set up for illumination channels with the relative 
locations of filters and Leoni optical fiber switch. Briefly, laser light (λ = 785 nm) was 
delivered into a fluorocarbon polymer (Cytop) fiber and passed through a short-pass filter into 
telescoping optics and coupled into the Leoni switch. A custom Matlab script was written to 
automatically illuminate individual excitation optical fibers E1-E5. Panel b shows the Raman 
spectrum of Cytop polymer with no short pass filter in the optical train (upper spectrum) and 
with an 842 nm short pass filter (bottom spectrum). 
2.3 Collection fiber bundle 
Figure 2 shows details of the collection fiber bundle. A collection fiber bundle was designed 
in-house and custom built with the goals of reducing fiber silicon signal and improving 
reproducibility in fiber placement (FiberTech Optica Inc., Kitchener, Ontario, Canada). The 
collection bundle had 50 total fibers consisting of 10 collection branches and 5 optical fibers 
within each collection branch. Low OH fibers were used to decrease fluorescence and Raman 
signal generated within the fibers [27]. Individual 100μm core optical fibers were 125μm after 
cladding and coating and had a numerical aperture of 0.22. Five individual fibers were placed 
in a bundle and those bundled fibers had a diameter of 0.33mm. The fiber bundle was 
encapsulated with a stainless steel ferrule to increase the sturdiness of the fiber tip and for a 
total diameter of 1.27mm. Even low OH silicon fibers generate Raman signals and 
fluorescence. Minimization of endogenous fiber signal enables higher Raman signal to 
background for the Raman bands of interest. Our approach was to use an optical fiber at the 
tip of each fiber bundle. A 785nm long pass filter was micro-milled and fit to the tip of the 
bundle ferrule, shown in Fig. 2(b). A photograph of the bundle tip is shown in Fig. 2(c) to 
show the 5 fibers. 
a b c 
 
Fig. 2. Panel a is an illustration of the collection fibers, with filtering affixed to the tip of the 
fiber generated in SolidWorks. A photograph in panel b was taken of two fibers showing the 
reflection of the laser filter at the fiber edge. Panel c is a direct view of an illuminated fiber 
bundle showing the placement of the 5 fibers inside the bundle. 
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2.4 Probe-to-tissue interface 
The probe-to-tissue interface was completely redesigned to accommodate additional fibers, 
improve fiber positioning and compatibility with the microCT instrument. The redesign also 
addressed requirements to design a holder that was efficient, compact and versatile. Figure 3 
shows the CAD schematics of the fiber holder created in Solidworks (Dassault Systemes 
Solidworks Corp. Waltham, MA, USA). The holder was built with 3D print technology and 
parts were printed on an Objet250 (Stratasys Ltd., Eden Prairie, Minnesota). 
 
Fig. 3. CAD diagram of the redesigned fiber holder generated with smaller angular separation 
between fiber guides and a smaller OD. These features enabled 15 fibers, an improvement over 
the 12 fibers used in an older model. The fiber holder is easily affixed to a patient bed, and the 
materials and dimensions are compatible with microCT instrument. 
This approach enabled fabrication of smaller-sized features that were not possible using a 
traditional machining approach. Fiber guides were created for 15 fibers, 10 collection fibers 
and 5 excitation fibers, which was an improvement over the 12 total fibers in previous 
holders. The connecting apparatus which affixed the two pieces of the holder was also 
redesigned to allow for greater stability and easier fitting with a split where the top 9 fibers 
and holder can quickly be placed or removed, and the connecting apparatus was held in place 
by 4 nylon set screws. 
2.5 Raman data preprocessing and image formation 
Calibration of the instrument was performed by collecting spectra of NIST-traceable white 
light and neon emission lamp to calibrate the wavenumber axis and correct for wavelength-
dependent variations in CCD efficiency. Raman spectra of Teflon or acetaminophen were 
acquired to correct the Raman shift for laser wavelength [28]. White light measurements from 
each collection fiber bundle were used to calculate which detector pixels corresponded to the 
collection fiber bundle. Correction of tissue autofluorescence signal was performed using a 
polynomial subtraction method adapted from a report by Zhao et al [29]. In tissue-simulating 
phantoms and rat specimens, Raman bands corresponding to bone hydroxyapatite mineral at 
~958 cm−1 and Cytop polymer at ~692 cm−1 were identified. Data points for tomographic 
reconstruction were determined by peak maxima values, integrated band area values or ratios 
(either intensity or area) of two Raman peaks of interest. Tissue phantom data were analyzed 
by calculating the intensity ratio of hydroxyapatite band to Cytop band for each collection 
fiber bundle and plotting the intensity ratio against the concentration of the hydroxyapatite 
inclusion or inclusion diameter. 
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Raman and microCT data were used to generate a tomographic reconstruction. 
Tomographic reconstructions required the generation of a volume mesh representing soft 
tissue and bone tissue regions with differing optical properties. DICOM images from 
microCT scans were segmented into regions for animal experiments. Segmentations were 
passed through NIRFAST software for generation of finite element meshes. Placement of 
source and detectors on the surface of the mesh, is guided by the presence of the fiber guides 
in the DICOM images and the inclusion of the displacement and compression of skin tissue 
which occurs during experimentation, which is important to include due to the applied 
pressure affecting tissue optical properties [30]. 
Images of the tomographic reconstructions were generated by iterative solving of the 
diffusion approximation in NIRFAST, with the driving mechanism being the minimization of 
the difference between the experimental measurements and the modeled data. Images 
represented the location and intensity of generated Raman photons, known as Raman yield. 
Tomographic reconstructions of the Raman yield were performed with both diffuse and a 
priori techniques [23]. A priori, or hard prior reconstruction techniques include region 
location within the tissue volume with the mesh node information and forces homogeneous 
recovered signals. The final image of the reconstruction algorithm was used to determine the 
contrast to background ratio (CBR), corresponding to the recovered hydroxyapatite to Cytop 
ratio for the bone region divided by the soft tissue region. 
2.6 Validation studies in tissue phantoms 
Validation studies were performed in tissue-simulating phantoms. We examined the effect of 
varying hydroxyapatite concentration for a defined “bone” tissue volume on normalized 
Raman hydroxyapatite signal. Cylindrical tissue phantoms were prepared to model the optical 
properties and approximate geometry of rat tibia bone and overlying soft tissue. Phantoms 
were made with total 25mm diameter to model the rat soft tissue dimensions at the tibia mid-
diaphysis with an 8.5mm diameter “bone” inclusion at the imaging plane. Gelatin phantoms 
were prepared using recipes previously described [7]. Briefly, the outer “soft tissue” phantom 
consisted of 10% (w/v) gelatin (Accumedia Manufacturers Inc., Lansing, MI, USA) with 10% 
(v/v) Liposyn II (Hospira Inc, Lake Forest, IL, USA). The gelatin solution was poured into a 
petri dish and allowed to cool. Once solidified, a 25 mm diameter and 18 mm high cylinder 
was cut from the bulk and a small hole was cut from off-center using a pipette tip. This hole 
was the site for the inner “bone” inclusion. The inner “bone” phantom was prepared by 
adding hydroxyapatite (HAp, SigmaAldrich, St. Louis, MO, USA) to 1 ml of a gelatin + 10% 
Liposyn II solution and poured into a 1.0 ml centrifuge tube. The tube was gently stirred to 
ensure minimal settling of HAp during solidification. The inner “bone” inclusion was ~8.5 
mm diameter. In total, 7 “bone” inclusions were prepared at HAp concentrations of 50, 100, 
150, 200, 225, 250 and 300 mg/ml. A control “bone” inclusion, composed of 0 mg/ml HAp + 
gelatin + 10% Liposyn II, was also prepared. For reference, the physiologic HAp 
concentration in bone is approximately 220 mg/ml [31]. The “bone” inclusions were 
examined as followed: once inside the centrifuge tube (Fig. 4(b)) and in duplicate after it had 
been removed from the tube (Fig. 4(c)). 
#226275 - $15.00 USD Received 5 Nov 2014; revised 15 Jan 2015; accepted 15 Jan 2015; published 11 Feb 2015 
(C) 2015 OSA 1 Mar 2015 | Vol. 6, No. 3 | DOI:10.1364/BOE.6.000793 | BIOMEDICAL OPTICS EXPRESS 799 
C1
C2
C3
C4C5
C6
C7
C8
C9
C10
E1
E2
E3
E4
E5
90◦ (88◦)
45◦
(44◦)
135◦
(132◦)
180◦
(172◦) E2 
source
a b
c
 
Fig. 4. Photograph (panel a) of an example tissue phantom in the fiber holder. During 
experiments, the “bone” inclusion was removed from the centrifuge tube and inserted into the 
outer “soft tissue” phantom. The illumination pattern is shown on the interior of the fiber 
holder, using E1-E5 to denote excitation fibers and C1-C10 to denote collection fibers. E2 was 
the excitation fiber used. Raman data were collected from all 10 collection fibers. Approximate 
degrees of separation for C2, C5, C6 and C8 are shown exterior to the fiber holder. Data from 
these collection fibers are presented in Figs. 7 and 8. Panel b is a cartoon of the bone inclusion 
inside the phantom while inside the polymer centrifuge tube, representing a 2-layer inclusion. 
Panel c is a cartoon of the bone inclusion inside the phantom after it has been removed from 
the polymer centrifuge tube, representing a single layer inclusion. 
Phantoms were stored in an airtight container at 4◦C when not in use and measured within 
a week of preparation. For Raman measurements, the phantom was placed into the patient 
interface, shown in Fig. 4 and excitation fiber 2 was used to illuminate the phantom. We used 
the excitation/collection fiber pattern that was optimized for in vivo use, denoted in Fig. 4. 
The optimized fiber pattern was determined using a cadaver animal, where the possible 
illumination patterns were tested to ensure sufficient excitation light delivery to the region of 
interest while still generating a full tomographic data set. Results were analyzed to determine 
greatest Raman signal from the bone and highest level of consistency in producing data above 
the noise floor. Additionally, this illumination pattern was chosen as the grouping of 
excitation fibers near the bone generates the greatest fluence while having sufficient number 
of detection fibers near. 
Raman signal was collected for 600 seconds to obtain a good signal-to-noise spectrum 
that did not require post-processing smoothing correction. In order to ensure consistent fiber 
alignment during this study, the fibers were not moved in between measurements. Only the 
“bone” inclusion was removed after the measurement while keeping the outer “soft tissue” 
phantom in place. Another “bone” inclusion, at a different HAp concentration was then 
inserted into the inclusion site and a Raman spectrum was collected. The “bone” inclusions 
were examined in random order. 
2.7 Validation studies in cadaveric and live rat specimens 
The second series of validation studies was performed in cadaveric (n = 2) and live (n = 1) 
rats. The illumination/collection pattern, interface setup time and signal collection parameters 
were optimized in cadaveric rat specimens. Parameters were adjusted to have the highest 
signal to noise ratio while remaining within the time restraints of animal experimentation. The 
live rat was obtained from another study which was approved by the University of Michigan 
University Committee on the Care and Use of Animals. Skeletally mature 6 month old male 
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Sprague-Dawley rats were sacrificed as part of another study. Frozen cadaveric rats were 
brought to room temperature and the right tibia was prepared for examination by the Raman 
system and microCT. Fur was removed from the right tibia using either an electric razor or a 
depilatory. A thin layer of glycerol was applied to the skin to facilitate fiber coupling to the 
tissue. Fibers were placed in the fiber guides until the fiber made close contact with the skin 
and the guide was tightened in place with a set screw. 
The ability to reproduce measured signals accurately without physically moving of fibers 
was tested with a cadaveric rat specimen. Spectra were acquired for 180, 300 and 600 seconds 
to determine an optimal measurement time. After polynomial fitting to remove background 
signal, the Cytop and hydroxyapatite signals were calculated and the average of signal 
intensity for 10 detection fibers when illuminated closest to the bone site was taken as the 
data point, shown in Fig. 5. 
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Fig. 5. Multiple Raman measurements were collected from the same animal without changing 
the location of the optical fibers to determine the linearity of Cytop and Raman signals with 
integration time. As expected, Cytop and Raman signals scale linearly with time. This study 
suggests that a minimal integration time of 69 seconds, indicated by a black X, in the “Fit to 
Raman Data” trend line would provide Raman signal above the noise floor. 
The pattern of excitation and collection fibers around the imaging place was also 
iteratively moved to optimize collection of transcutaneous bone signal. The optimized pattern, 
also used for tissue phantom and live rat measurements, is shown in Fig. 4. The patient 
interface in use on a live, anesthetized, rat is shown in Fig. 6a and a cross section view from 
the microCT scan in Fig. 6(b) shows moderate tissue indentation at sites where the fiber 
guides are in contact with the tissue. 
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Fig. 6. Panel a shows a rat tibia in the fiber holder with fibers placed around the leg. Panel b 
shows a microCT image showing the fiber guides on the surface and the deformation caused 
by placement on the exterior of the leg. Areas in pink are the tibia and fibula and the area 
colored in green represents soft tissue consisting of muscle, tendon and skin. 
In another study, repeatability tests were performed by collecting Raman data from a rat 
specimen for two consecutive days. Tomographic reconstructions were performed and the 
normalized bone Raman parameter for the bone region to the background was determined for 
diffuse and hard prior reconstructions. 
3. Results 
3.1 Assessing Cytop as a reference intensity standard 
Earlier studies had described the use of a fluoropolymer fiber as a reference intensity standard 
[32]. However, we found significant overlapping Cytop signal in the bone matrix region 
(1200-1800 cm−1). Cytop signal could not be removed using software subtraction routines 
without affecting the shape of important bone collagen band envelopes. As shown in Fig. 
1(b), inclusion of an 842 nm short pass filter into the illumination system removed bands in 
the 1200-1800 cm−1 spectral region. As shown in Fig. 5, Cytop signal scaled linearly with 
acquisition time. Linear fitting of these data points generated a R2 value of 1 for the Raman 
data and 0.9992 for the Cytop data. The location of the x-intercept on the Raman line, marked 
with a black X in Fig. 5, indicates the minimum exposure time necessary for a signal above 
the noise floor, which is equivalent to 69 seconds. However, experimental times longer than 
69 seconds would be required to obtain significant Raman signal. These data suggest that 
Cytop polymer fibers are suitable for a reference standard in fiber-optic Raman 
measurements. 
3.2 Tissue Phantom Validation Studies 
Data from tissue phantom and rat specimens demonstrate feasibility of transcutaneous bone 
measurements. In general, we found that the third-generation instrument generated high 
quality spectroscopic and imaging data, with improved ergonomics and compatibility with 
microCT. Initial tissue phantom data shows good linearity of HAp signal and suggests that, 
while most of the sampling occurs at the “bone” surface, there is some subsurface sampling. 
The sensitivity of the system was determined through phantoms with decreasing contrast to 
background values. Tomographic measurements allowed for simultaneous measurement of 
the reference Cytop polymer and HAp Raman signals. The baselined intensity value for all 
source detector pairs was calculated from the spectrum. Normalized HAp Raman data for 
source-detector separations at approximately 45, 90, 135 and 180 degrees were plotted against 
HAp concentration, shown in Fig. 7. 
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Fig. 7. Raman spectra of tissue phantoms were used to determine noise floor and attenuation 
region for the measurement of hydroxyapatite (HAp) with the current system. These 
measurements were performed with the bare bone inclusion after it was removed from the 
plastic centrifuge tube. Raman HAp signal normalized to Cytop Raman signal is shown against 
the concentration of HAp in the “bone” inclusion. Collection signal from collection fibers 
corresponding to approximately 45◦, 90◦, 135◦ and 180◦ are presented. 
The data show that the normalized HAp Raman signal increased with concentration and 
generally followed a linear relationship for all source-detector pairs. The data from this 
phantom test supports our hypothesis that the instrumentation provides suitable contrast, at all 
degrees of collection, for physiologically-relevant HAp concentrations. These results suggest, 
at physiological levels of HAp, most of the Raman photons are being generated at the surface 
of the inclusion and little light is propagated through the inclusion. 
Even though phantom data indicate minimal photon propagation through the inclusion, 
our tests suggest that subsurface sampling of the inclusion does occur. Measurements of the 
2-layer bone inclusion, with the bone phantom + the plastic centrifuge tube, shown in Fig. 
4(b), demonstrated recovery of both tube material and HAp signal. Figure 8(a) shows 
averaged Raman spectra of tissue phantoms with the bone inclusion inside the centrifuge tube 
material. As expected, the spectra show contributions from Cytop and the centrifuge tube 
material (denoted by a * in the figure). However, we were also able to recover subsurface 
hydroxyapatite signal. Figure 8(b) shows the normalized HAp signal as a function of HAp 
concentration. The R2 values of trend lines were >0.9 for 45, 90 and 135 degrees, indicating a 
linear response. We observed similar trends of increased spread in the data at high HAp 
concentrations and less variability in signal recovered from fibers closer to the illumination 
source. 
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Fig. 8. Raman spectra of tissue phantoms were used to determine noise floor and attenuation 
region for the measurement of HAp with the current system. These measurements were 
performed with the 2-layer bone inclusion, which was the “bone” phantom inside its plastic 
centrifuge tube. Panel a shows Raman HAp signal normalized to Cytop Raman signal is shown 
against the concentration of HAp in the “bone” inclusion. The spectra show signatures from 
Cytop, centrifuge material (denoted with an *) and HAp. The control inclusion does not have 
any signatures from HAp. Panel b shows normalized HAp signal from collection fibers 
corresponding to approximately 45◦, 90◦, 135◦ and 180◦. The data shows trends of increased 
Raman signal collected at 180◦ and increased spread at higher HAp concentrations. 
3.3 Rat specimen validation studies 
An in vivo animal protocol was developed for sequential acquisition of Raman and microCT 
data sets. Based on the advice of our animal handling experts, we established a maximum 
experiment time of 50 minutes. The Raman and microCT measurements together take 40 
minutes, leaving only 10 minutes to place the tibia into the holder and set up the fiber system. 
A streamlined workflow enabled rapid (7 minutes) Raman probe setup in a cadaveric rat and 
we tested this workflow on a live anesthetized rat. The described optimized workflow is also 
used in our ongoing in vivo longitudinal study of a rat fracture healing model. We observed 
that live rats generally tolerated the Raman/microCT procedure well. There were temporary 
indentations on the skin caused by contact of the fiber guides, which persisted less than an 
hour after the procedure. The indentations did not penetrate the skin or restrict the animal’s 
movement. 
Optical measurements were acquired on two consecutive days for the in vivo study and a 
comparison of the reconstruction results was done to determine the effect of day-to-day 
variations. Reconstructions completed with diffuse parameters led to a mean normalized CBR 
value of 2.4 ± 0.3 over the two days. Inclusion of hard priors in the reconstruction led to a 
mean CBR value of 9.6 ± 6.3. The contrast to background ratio for each day of measurements 
is presented in Table 1. 
Table 1. Contrast to background values for diffuse Raman reconstructions from data 
acquired on a live rat indicating the day-to-day variation in recovered bone to cytop 
signal within the bone region compared to the soft tissue region as defined in the 
microCT images used for image segmentation. 
Experiment Date Diffuse Hard 
January 29 2.6 14.1 
January 30 2.2 5.2 
4. Discussion 
The third-generation system makes important improvements to earlier prototypes that enable 
quantitative Raman tomography and improved image reconstruction. Importantly, 
tomographic reconstructions were completed using a full 360 degrees of data collection rather 
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than a SORS-type backscatter measurement on the same surface of the leg [18, 19, 25, 26]. 
We have demonstrated feasibility of transcutaneous Raman tomography. 
The Raman tomography instrumentation used in our previous studies had major 
instrumentation limitations that our new design addresses. We discuss four improvements to 
the instrument; the removal of metal from the holder, the inclusion of increased locations for 
illumination fibers through a fiber switch, an internal reference in Cytop, and laser line 
filtering with submillimeter filters at the tip of collection fibers. 
A major limitation in previous prototypes was the use of metal rings to hold the specimen 
rigid and align the fibers with the surface [21]. However, the metal holder made coupling to 
microCT impractical. We have addressed this concern by fabricating the new holder entirely 
from polymers which allows for the collection of microCT scans without removing the fiber 
holder. The second instrumentation limitation in previous design was the use of a single fiber 
as the excitation source. This limitation in probe design required the single fiber to be 
manually moved from position to position around the ring which increased fiber placement 
errors and prolonged the experiment time. To address this second major issue, the new design 
uses 5 excitation fibers and a fiber switch, eliminating the need to manually switch excitation 
fiber positions. 
We have also included improvements to the laser delivery system. Inclusion of a filtered 
Cytop fiber section, for measurement of a reference standard signal, corrects for coupling 
variations. This approach is similar to the Born technique used in other diffuse tomography 
studies [33]. Integration of a fiber switch into the illumination pathway allows for a reduction 
in the fiber coupling error while selectively illuminating one fiber for excitation. To our 
knowledge, this is the first report of incorporating of a laser line filter at the tip of the 
collection bundles with a submillimeter diameter. While other groups have reported laser line 
filtering, the diameter of the filter was limited to commercially available sizes. Our micro-
milling approach now enables laser line filtering for micrometer diameter probes. The 
technological features in the described system can be extended to other fiber-optic Raman 
probes. 
Phantom measurements enabled us to characterize the instrument response to bone-like 
mineral levels. The geometry of a cylindrical tissue phantom approximates the plane in which 
the Raman tomography measurements were made on rat tibiae. We showed evidence that 
subsurface sampling of a bone inclusion is possible using our instrumentation. This 
observation may have important implications for non-invasive measurement of cancellous 
bone, where more rapid bone remodeling events occur than in cortical bone. Further tests in 
rat bone tissue are underway to confirm these tissue phantom results. Similar tissue phantoms 
can be made to model potential clinical conditions including generalized bone mineral loss or 
localized bone erosion. Anthromorphic phantoms described by Esmonde-White et al and 
Michaelsen et al would enable a multivariate model to simultaneously measure a defined 
bone volume and hydroxyapatite levels [7, 34]. 
Our in vivo animal protocol allowed us to complete our measurements in the 
recommended time. We confirmed no permanent damage to the rats. Day-to-day variations in 
the contrast to background is most likely affected by subjective variables such as user 
experience. These may manifest in placement of the fiber pattern and location with respect to 
the bone. We also found the amount of pressure applied to the surface by the fibers and fiber 
guides can affect the efficiency in which light couples into the tissue. For hard prior 
reconstructions small changes in the amount of signal caused by any of these parameters can 
lead to large variations in the reconstructed values. 
Non-invasive Raman measurement of bone in an in vivo setting has important 
implications for the future musculoskeletal diagnostics. While we report the Raman 
tomography instrument using phantoms or rat specimens, the probe-to-tissue interface can be 
scaled to accommodate human-sized anatomic sites such as the distal radius and fingers. 
Extension to multiplane tomography in the clinic can be achieved through the addition of 
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multiple fiber holders and detectors, with the eventual goal of a custom-designed interface for 
human use. Our experimental approach and instrumentation was designed with an eventual 
goal of in vivo human use. An important consideration is laser safety. Preclinical animal 
studies do not define maximum laser exposure limits. Nonetheless, we anticipated 
translational studies in humans using comparable technology. As such, our rat measurements 
used the American National Standards Institute (ANSI) guideline, Z136.1-2007 of maximum 
permissible exposure (MPE) for continuous illumination (t = 10 sec-30000 sec) in humans. In 
human tissue, the ANSI guideline for MPE is 0.3W/cm2 in the wavelength range 750-1050 
nm and we used a similar MPE for our rat measurements [13]. Even though higher laser 
intensities can be used for diagnostic purposes, we believe adoption of this conservative 
guideline has facilitated favorable review of our approved human clinical study protocols (n = 
2) by the University of Michigan Institutional Review Board. 
We foresee two possible areas of clinical applications for the Raman tomography 
technology in bone diseases. The first clinical application area is transcutaneous 
measurements of bone demineralization at the distal radius which may be indicative of 
osteoporosis or other metabolic bone diseases. The second potential clinical application area 
is transcutaneous Raman measurements of periarticular bone erosions at the fingers which 
may be encountered in rheumatoid arthritis. 
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